4-Cyano-1H-imidazole-2-carboxylic acid {2-(4,4-dimethyl-cyclohex-1-enyl)-6-[1-(2-pyrrolidin-1-yl-ethoxy)-cyclopentyl]-pyridin-3-yl}-amide

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: 4-Cyano-1H-imidazole-2-carboxylic acid {2-(4,4-dimethyl-cyclohex-1-enyl)-6-[1-(2-pyrrolidin-1-yl-ethoxy)-cyclopentyl]-pyridin-3-yl}-amide
• 英文别名: 5-cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-[1-(2-pyrrolidin-1-ylethoxy)cyclopentyl]pyridin-3-yl]-1H-imidazole-2-carboxamide
• 化学式: C₂₉H₃₈N₆O₂
• 分子量: 502.66
• InChiKey: KVIXVPMXEKFOEJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.9
• 重原子数：
  37
• 可旋转键数：
  8
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.59
• 拓扑面积：
  107
• 氢给体数：
  2
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  N-(2-羟乙基)-吡咯烷 、 4-cyano-1H-imidazole-2-carboxylic acid [2-(4,4-dimethyl-cyclohex-1-enyl)-4-(1-hydroxy-cyclopentyl)-phenyl]-amide 在 三氟乙酸 作用下， 反应 8.0h， 生成 4-Cyano-1H-imidazole-2-carboxylic acid {2-(4,4-dimethyl-cyclohex-1-enyl)-6-[1-(2-pyrrolidin-1-yl-ethoxy)-cyclopentyl]-pyridin-3-yl}-amide
  参考文献：
  名称：

  INHIBITORS OF C-FMS KINASE

  摘要：

  该发明涉及以下式I的化合物：其中Z、X、J、R2和W如规范中所述，以及其溶剂合物、水合物、互变异构体和药用盐，能够抑制蛋白酪氨酸激酶，尤其是c-fms激酶。还提供了使用该化合物治疗自身免疫性疾病；有炎症成分的疾病；治疗卵巢癌、子宫癌、乳腺癌、前列腺癌、肺癌、结肠癌、胃癌、毛细胞白血病引起的转移；治疗疼痛，包括肿瘤转移或骨关节炎引起的骨骼疼痛，或内脏、炎症和神经源性疼痛；以及骨质疏松症、帕盖特氏病和其他骨吸收介导发病率的疾病，包括类风湿关节炎和其他形式的炎症性关节炎、骨关节炎、假体失败、溶骨性肉瘤、骨髓瘤和肿瘤转移至骨骼的方法。

  公开号：

  US20070249608A1

文献信息

• US8815867B2
  申请人：——

  公开号：US8815867B2

  公开（公告）日：2014-08-26
• US9403804B2
  申请人：——

  公开号：US9403804B2

  公开（公告）日：2016-08-02
• [EN] INHIBITORS OF C-FMS KINASE<br/>[FR] INHIBITEURS DE LA KINASE DE C-FMS
  申请人：JANSSEN PHARMACEUTICA NV

  公开号：WO2007124322A1

  公开（公告）日：2007-11-01

  [EN] The invention is directed to compounds of Formula (I): wherein Z, X, J, R² and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula (I), are also provided.
  [FR] L'invention concerne des composés de formule (I), dans laquelle Z, X, J, R² et W sont tels que définis dans la description, ainsi que des solvates, des hydrates, des tautomères et des sels pharmaceutiquement acceptables de ces composés, qui inhibent les tyrosine kinases de protéines, en particulier la kinase de c-fms. L'invention concerne également des procédés de traitement de maladies auto-immunes et de maladies à composante inflammatoire ; de traitement de métastases de cancer de l'ovaire, de l'utérus, du sein, de la prostate, du poumon, du côlon, de l'estomac, de la leucémie à tricholeucocytes ; et de traitement de la douleur, y compris la douleur squelettique due à une métastase tumorale ou à l'ostéoarthrite, ou la douleur viscérale, inflammatoire et neurogène ; ainsi que de l'ostéoporose, la maladie de Paget et d'autres maladies dans lesquelles la résorption osseuse médie une morbidité, y compris la polyarthrite rhumatoïde et d'autre formes d'arthrite inflammatoire, l'ostéoarthrite, l'échec de la pose de prothèse, le sarcome ostéolytique, le myélome et les métastases tumorales à l'os en utilisant les composés de formule (I).
• INHIBITORS OF C-FMS KINASE
  申请人：Illig Carl R.

  公开号：US20070249608A1

  公开（公告）日：2007-10-25

  The invention is directed to compounds of Formula I: wherein Z, X, J, R 2 and W are set forth in the specification, as well as solvates, hydrates, tautomers and pharmaceutically acceptable salts thereof, that inhibit protein tyrosine kinases, especially c-fms kinase. Methods of treating autoimmune diseases; and diseases with an inflammatory component; treating metastasis from ovarian cancer, uterine cancer, breast cancer, prostate cancer, lung cancer, colon cancer, stomach cancer, hairy cell leukemia; and treating pain, including skeletal pain caused by tumor metastasis or osteoarthritis, or visceral, inflammatory, and neurogenic pain; as well as osteoporosis, Paget's disease, and other diseases in which bone resorption mediates morbidity including rheumatoid arthritis, and other forms of inflammatory arthritis, osteoarthritis, prosthesis failure, osteolytic sarcoma, myeloma, and tumor metastasis to bone with the compounds of Formula I, are also provided.

  该发明涉及以下式I的化合物：其中Z、X、J、R2和W如规范中所述，以及其溶剂合物、水合物、互变异构体和药用盐，能够抑制蛋白酪氨酸激酶，尤其是c-fms激酶。还提供了使用该化合物治疗自身免疫性疾病；有炎症成分的疾病；治疗卵巢癌、子宫癌、乳腺癌、前列腺癌、肺癌、结肠癌、胃癌、毛细胞白血病引起的转移；治疗疼痛，包括肿瘤转移或骨关节炎引起的骨骼疼痛，或内脏、炎症和神经源性疼痛；以及骨质疏松症、帕盖特氏病和其他骨吸收介导发病率的疾病，包括类风湿关节炎和其他形式的炎症性关节炎、骨关节炎、假体失败、溶骨性肉瘤、骨髓瘤和肿瘤转移至骨骼的方法。